With such a focus these days on buzzwords such as « patient-centric, » « patient-centered, » and « patient-centricity, » some people are predicting “patient engagement” to be the next big movement in our industry, much as blockbuster drugs were a decade or more ago. But while improving patient engagement sounds fairly straightforward for those who directly interact with patients (e.g., doctors, nurses, nurse practitioners, and physicians assistants), for the biopharmaceutical industry, successfully executing this concept has been — and continues to be — much more challenging.

Source: www.lifescienceleader.com